Impact of Body Mass Index on Efficacy of Benralizumab in Patients with Severe, Uncontrolled Eosinophilic Asthma: Pooled Analysis of the SIROCCO and CALIMA Trials-MedSci.cn

Impact of Body Mass Index on Efficacy of Benralizumab in Patients with Severe, Uncontrolled Eosinophilic Asthma: Pooled Analysis of the SIROCCO and CALIMA Trials

Trudo, F; Hirsch, I; Gopalan, G; Martin, U

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018; 197 ():

科室
- - 订阅+
  - 更多科室
工具
服务